Status:
COMPLETED
Group Cognitive Behavioral Therapy Versus Fluoxetine for Obsessive-Compulsive Disorder: a Practical Trial
Lead Sponsor:
University of Sao Paulo
Collaborating Sponsors:
Fundação de Amparo à Pesquisa do Estado de São Paulo
Conditions:
Obsessive Compulsive Disorder
Eligibility:
All Genders
18-65 years
Phase:
PHASE4
Brief Summary
First line treatments fo Obsessive Compulsive Disorder (OCD) are Selective Serotonin Recapture Inhibitors (SSRIs) and Cognitive Behaviour Therapy (CBT) including exposure with response prevention. The...
Detailed Description
During the last decades, different pharmacological and psychotherapeutic strategies have been used to treat patients with obsessive compulsive disorder (OCD). Drugs that inhibit the serotonin recaptur...
Eligibility Criteria
Inclusion
- Having been diagnosed with primary OCD according to the criteria set forth in the DSM-IV;
- Current symptoms causing significant distress (YBOCS score greater than 16);
- Not receiving current adequate treatment;
- Accepting to participate in the study
Exclusion
- Having a clinical or neurological disease that might be worsened by the medicines included in the treatment protocol;
- Presenting current substance dependence or abuse;
- Exhibiting current psychotic symptoms; being currently at risk for suicide;
- And, being pregnant or having the intention to become pregnant prior to the end of the treatment protocol
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
158 Patients enrolled
Trial Details
Trial ID
NCT00680602
Start Date
January 1 2006
End Date
September 1 2008
Last Update
February 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute of Psychiatry, Clinics Hospital, University of São Paulo Medical School
São Paulo, São Paulo, Brazil, 05403-010